Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (LUTRAERL)

Clinical Trial ID NCT00473083

PubWeight™ 3.15^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00473083

Top papers